USS Investment Management Ltd Has $6.84 Million Stock Position in Kenvue Inc. $KVUE

USS Investment Management Ltd boosted its position in shares of Kenvue Inc. (NYSE:KVUE) by 11.4% in the fourth quarter, Holdings Channel.com reports. The firm owned 395,958 shares of the company’s stock after purchasing an additional 40,372 shares during the period. USS Investment Management Ltd’s holdings in Kenvue were worth $6,840,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the company. Arrowstreet Capital Limited Partnership acquired a new stake in shares of Kenvue in the second quarter worth about $6,528,000. Jump Financial LLC lifted its position in shares of Kenvue by 210.6% in the second quarter. Jump Financial LLC now owns 54,823 shares of the company’s stock worth $1,147,000 after buying an additional 37,170 shares during the last quarter. AXA S.A. lifted its position in shares of Kenvue by 21.1% in the second quarter. AXA S.A. now owns 48,892 shares of the company’s stock worth $1,023,000 after buying an additional 8,524 shares during the last quarter. NewEdge Advisors LLC lifted its position in shares of Kenvue by 219.1% in the second quarter. NewEdge Advisors LLC now owns 97,481 shares of the company’s stock worth $2,040,000 after buying an additional 66,930 shares during the last quarter. Finally, The Manufacturers Life Insurance Company lifted its position in shares of Kenvue by 0.6% in the second quarter. The Manufacturers Life Insurance Company now owns 1,873,705 shares of the company’s stock worth $39,217,000 after buying an additional 10,885 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Insider Buying and Selling at Kenvue

In other news, General Counsel Matthew Orlando sold 38,491 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 1.59% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently commented on KVUE. Zacks Research upgraded Kenvue from a “hold” rating to a “strong-buy” rating in a research note on Friday, May 8th. Weiss Ratings lowered Kenvue from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 29th. UBS Group dropped their price objective on Kenvue from $19.00 to $18.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 7th. Canaccord Genuity Group lifted their price objective on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research note on Wednesday, February 18th. Finally, Barclays dropped their price objective on Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 14th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and twelve have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $19.33.

Kenvue Trading Up 0.6%

Shares of KVUE opened at $18.25 on Tuesday. Kenvue Inc. has a 12-month low of $14.02 and a 12-month high of $22.87. The company has a quick ratio of 0.70, a current ratio of 0.98 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $35.03 billion, a price-to-earnings ratio of 21.47, a P/E/G ratio of 1.38 and a beta of 0.54. The stock’s 50-day moving average price is $17.45 and its 200 day moving average price is $17.55.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The company had revenue of $3.91 billion for the quarter, compared to analyst estimates of $3.84 billion. During the same period in the prior year, the company posted $0.24 EPS. The company’s revenue was up 4.5% compared to the same quarter last year. As a group, research analysts predict that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th were paid a $0.2075 dividend. This represents a $0.83 annualized dividend and a dividend yield of 4.5%. The ex-dividend date was Wednesday, May 13th. Kenvue’s dividend payout ratio is currently 97.65%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.